Chemoresistance in pancreatic ductal adenocarcinoma

MicroRNA Profiling Implies New Markers of Gemcitabine ... - PLOS

No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene ...

A tunable delivery platform to provide local chemotherapy for ...

Citation. Indolfi, Laura et al. “A Tunable Delivery Platform to Provide Local Chemotherapy for Pancreatic Ductal Adenocarcinoma.” Biomaterials 93 (July 2016): ...

Comparing neoadjuvant chemotherapy with or without radiation ...

This study of pancreatic cancer using National Cancer Database data demonstrates that neoadjuvant chemoradiotherapy is associated with a ...

BICC1 drives pancreatic cancer stemness and chemoresistance by ...

However, the mechanisms sustaining stemness and chemotherapy resistance in pancreatic ductal adenocarcinoma (PDAC) remain unclear. Here, we ...

Modified Perioperative Chemotherapy Regimen May Benefit ...

Administering chemotherapy prior to and following surgery may extend survival in patients with pancreatic ductal adenocarcinoma compared ...

Survival Benefit of Adjuvant Chemotherapy in Patients with ...

In the adjuvant chemotherapy group, FOLFIRINOX (n=98, 65.8%) was administered most frequently followed by gemcitabine monotherapy (n=39, 26.2%) ...

Initial chemotherapy option for pancreatic ductal adenocarcinoma in ...

This article provides a review of the initial chemotherapy options for PDAC patients with adequate performance status, comparing FOLFIRINOX (oxaliplatin, ...

Targeted Therapy for Pancreatic Ductal Adenocarcinoma - YouTube

Innovations in Chemotherapy with Dr. Mandana Kamgar. Medical College of Wisconsin · 723 views ; Dr. Brunicardi - Personalized Targeted Therapies ...

Treating Pancreatic Cancer, Based on Extent of the Cancer

Chemotherapy, sometimes followed by chemoradiation, is the standard treatment option for locally advanced cancers. This may help some people ...

Full article: The role of miRNAs in the diagnosis, chemoresistance ...

Pancreatic ductal adenocarcinoma (PDAC) remains a very challenging malignancy with late presentation, metastatic potential, chemoresistance, ...

Epithelial to mesenchymal plasticity and differential response to ...

Transcriptional profiling has defined pancreatic ductal adenocarcinoma (PDAC) into distinct subtypes with the majority being classical ...

Novel discoveries targeting gemcitabine‐based chemoresistance ...

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ...

Lysyl oxidase family activity promotes resistance of pancreatic ductal ...

Solid tumors often display chemotherapy resistance. Pancreatic ductal adenocarcinoma (PDAC) is the archetype of resistant tumors as current ...

Pancreatic Adenocarcinoma - Guidelines Detail - NCCN

Distress During Cancer Care Esophageal Cancer Fatigue and Cancer Follicular Lymphoma Gallbladder and Bile Duct Cancers Gastrointestinal Stromal Tumors (GIST) ...

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer. 499 views · 1 year ago ...more. SSATVideos. 5.97K. Subscribe. 8. Share. Save.

Chemotherapy Protocols - BC Cancer

Digestive System Cancer · Anal · Bile Duct · Colorectal · Esophageal · Gallbladder · Liver · Liver, Secondary · Pancreatic · Small Bowel · Stomach · Eye Cancer ...

Pancreatic ductal adenocarcinoma and variants - Dr. Wood - YouTube

Help support pathCast by donating to assist with costs from streaming software, videoconference services, and information applications.

The Most Deadly and Least Aggressive Cancers - Verywell Health

The deadliest cancer types include lung cancer, colon cancer, and pancreatic cancer. However, assessing the most aggressive types depends on ...

Borderline Resectable Pancreatic Cancer - 06.24.20

... pancreatic, liver, and bile duct cancers. Dr. Abdelrahim is also the medical director of Cockrell Center for Advanced Therapeutics, where he is leading a ...

Debate: Optimal adjuvant chemotherapy for resected pancreatic ...

... chemotherapy for resected pancreatic cancer ... Chemotherapy and immunotherapy in treatment of gall bladder cancer and bile duct cancer.